Beneficient (NASDAQ:BENF – Get Free Report) was the recipient of a significant decline in short interest during the month of December. As of December 31st, there was short interest totalling 164,100 shares, a decline of 27.5% from the December 15th total of 226,400 shares. Based on an average daily volume of 2,090,000 shares, the days-to-cover ratio is presently 0.1 days. Currently, 4.4% of the company’s stock are short sold.
Insider Buying and Selling
In related news, Director Peter T. Cangany, Jr. acquired 75,000 shares of the business’s stock in a transaction on Tuesday, November 19th. The shares were bought at an average price of $0.93 per share, with a total value of $69,750.00. Following the completion of the acquisition, the director now owns 300,000 shares in the company, valued at $279,000. This trade represents a 33.33 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders sold a total of 17,729 shares of company stock worth $14,290 over the last 90 days. 13.69% of the stock is owned by insiders.
Hedge Funds Weigh In On Beneficient
A hedge fund recently raised its stake in Beneficient stock. Stifel Financial Corp increased its position in Beneficient (NASDAQ:BENF – Free Report) by 138.2% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 24,300 shares of the company’s stock after purchasing an additional 14,100 shares during the period. Stifel Financial Corp owned 0.57% of Beneficient worth $30,000 at the end of the most recent quarter. Institutional investors own 90.57% of the company’s stock.
Beneficient Trading Up 2.0 %
Beneficient Company Profile
Beneficient, a technology-enabled financial services company, provides liquidity solutions and related trustee, custody and trust administrative services to participants in the alternative asset industry in the United States. It operates through Ben Liquidity, Ben Custody, and Customer ExAlt Trusts segments.
Featured Articles
- Five stocks we like better than Beneficient
- Dividend Payout Ratio Calculator
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- Insider Trading – What You Need to Know
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- The 3 Best Blue-Chip Stocks to Buy Now
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for Beneficient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beneficient and related companies with MarketBeat.com's FREE daily email newsletter.